Skip to main content
Erschienen in: Pediatric Cardiology 7/2015

01.10.2015 | Original Article

Sedation and Anesthesia in Pediatric and Congenital Cardiac Catheterization: A Prospective Multicenter Experience

verfasst von: C. Huie Lin, Sanyukta Desai, Ramzi Nicolas, Kimberlee Gauvreau, Susan Foerster, Anshuman Sharma, Laurie Armsby, Audrey C. Marshall, Kirsten Odegard, James DiNardo, Julie Vincent, Howaida El-Said, James Spaeth, Bryan Goldstein, Ralf Holzer, Jackie Kreutzer, David Balzer, Lisa Bergersen

Erschienen in: Pediatric Cardiology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Sedation/anesthesia is critical to cardiac catheterization in the pediatric/congenital heart patient. We sought to identify current sedation/anesthesia practices, the serious adverse event rate related to airway, sedation, or anesthesia, and the rate of intra-procedural conversion from procedural sedation to the use of assisted ventilation or an artificial airway. Data from 13,611 patients who underwent catheterization at eight institutions were prospectively collected from 2007 to 2010. Ninety-four (0.69 %) serious sedation/airway-related adverse events occurred; events were more likely to occur in smaller patients (<4 kg, OR 4.4, 95 % CI 2.3–8.2, p < 0.001), patients with non-cardiac comorbidities (OR 1.7, 95 % CI 1.1–26, p < 0.01), and patients with low mixed venous oxygen saturation (OR 2.3, 95 % CI 1.4–3.6, p < 0.001). Nine thousand three hundred and seventy-nine (69 %) patients were initially managed with general endotracheal anesthesia, LMA, or tracheostomy, whereas 4232 (31 %) were managed with procedural sedation without an artificial airway, of which 75 (1.77 %) patients were converted to assisted ventilation/general anesthesia. Young age (<12 months, OR 5.2, 95 % CI 2.3–11.4, p < 0.001), higher-risk procedure (category 4, OR 10.1, 95 % CI 6.5–15.6, p < 0.001), and continuous pressor/inotrope requirement (OR 11.0, 95 % CI 8.6–14.0, p < 0.001) were independently associated with conversion. Cardiac catheterization in pediatric/congenital patients was associated with a low rate of serious sedation/airway-related adverse events. Smaller patients with non-cardiac comorbidities or low mixed venous oxygen saturation may be at higher risk. Patients under 1 year of age, undergoing high-risk procedures, or requiring continuous pressor/inotrope support may be at higher risk of requiring conversion from procedural sedation to assisted ventilation/general anesthesia.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
Three cases had two adverse events each such that 252 events occurred in 249 cases. To avoid double-counting, 249 events were used for subsequent statistics.
 
Literatur
1.
Zurück zum Zitat Andropoulos DB (2004) Anesthetic agents and their cardiovascular effects. In: Andropoulos DB, Stayer SA, Russel I, Mossad EB (eds) Anesthesia for congenital heart disease. Wiley-Blackwell, West Sussex, pp 77–92 Andropoulos DB (2004) Anesthetic agents and their cardiovascular effects. In: Andropoulos DB, Stayer SA, Russel I, Mossad EB (eds) Anesthesia for congenital heart disease. Wiley-Blackwell, West Sussex, pp 77–92
2.
Zurück zum Zitat Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, Saager L, Turner MS, Rao S, Bottros M, Hantler C, Jacobsohn E, Evers AS (2008) Anesthesia awareness and the bispectral index. N Engl J Med 358:1097–1108CrossRefPubMed Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, Saager L, Turner MS, Rao S, Bottros M, Hantler C, Jacobsohn E, Evers AS (2008) Anesthesia awareness and the bispectral index. N Engl J Med 358:1097–1108CrossRefPubMed
3.
Zurück zum Zitat Bergersen L, Marshall A, Gauvreau K, Beekman R, Hirsch R, Foerster S, Balzer D, Vincent J, Hellenbrand W, Holzer R, Cheatham J, Moore J, Lock J, Jenkins K (2010) Adverse event rates in congenital cardiac catheterization—a multi-center experience. Catheter Cardiovasc Interv 75:389–400PubMed Bergersen L, Marshall A, Gauvreau K, Beekman R, Hirsch R, Foerster S, Balzer D, Vincent J, Hellenbrand W, Holzer R, Cheatham J, Moore J, Lock J, Jenkins K (2010) Adverse event rates in congenital cardiac catheterization—a multi-center experience. Catheter Cardiovasc Interv 75:389–400PubMed
4.
Zurück zum Zitat Bergersen L, Gauvreau K, Foerster SR, Marshall AC, McElhinney DB, Beekman RH 3rd, Hirsch R, Kreutzer J, Balzer D, Vincent J, Hellenbrand WE, Holzer R, Cheatham JP, Moore JW, Burch G, Armsby L, Lock JE, Jenkins KJ (2011) Catheterization for congenital heart disease adjustment for risk method (charm). JACC Cardiovasc Interv 4:1037–1046CrossRefPubMed Bergersen L, Gauvreau K, Foerster SR, Marshall AC, McElhinney DB, Beekman RH 3rd, Hirsch R, Kreutzer J, Balzer D, Vincent J, Hellenbrand WE, Holzer R, Cheatham JP, Moore JW, Burch G, Armsby L, Lock JE, Jenkins KJ (2011) Catheterization for congenital heart disease adjustment for risk method (charm). JACC Cardiovasc Interv 4:1037–1046CrossRefPubMed
5.
Zurück zum Zitat Bergersen L, Everett AD, Giroud JM, Martin GR, Franklin RCG, Béland MJ, Krogmann ON, Aiello VD, Colan SD, Elliott MJ, Gaynor JW, Kurosawa H, Maruszewski B, Stellin G, Tchervenkov CI, Walters HLI, Weinberg P, Jacobs JP (2011) Report from the international society for nomenclature of paediatric and congenital heart disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (part 1—procedural nomenclature). Cardiol Young 21:252–259CrossRefPubMed Bergersen L, Everett AD, Giroud JM, Martin GR, Franklin RCG, Béland MJ, Krogmann ON, Aiello VD, Colan SD, Elliott MJ, Gaynor JW, Kurosawa H, Maruszewski B, Stellin G, Tchervenkov CI, Walters HLI, Weinberg P, Jacobs JP (2011) Report from the international society for nomenclature of paediatric and congenital heart disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (part 1—procedural nomenclature). Cardiol Young 21:252–259CrossRefPubMed
6.
Zurück zum Zitat Cote CJ, Wilson S (2006) Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: an update. Pediatrics 118:2587–2602CrossRefPubMed Cote CJ, Wilson S (2006) Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: an update. Pediatrics 118:2587–2602CrossRefPubMed
7.
Zurück zum Zitat Durand E, Borz B, Godin M, Tron C, Litzler PY, Bessou JP, Bejar K, Fraccaro C, Sanchez-Giron C, Dacher JN, Bauer F, Cribier A, Eltchaninoff H (2012) Transfemoral aortic valve replacement with the edwards sapien and edwards sapien xt prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv 5:461–467CrossRefPubMed Durand E, Borz B, Godin M, Tron C, Litzler PY, Bessou JP, Bejar K, Fraccaro C, Sanchez-Giron C, Dacher JN, Bauer F, Cribier A, Eltchaninoff H (2012) Transfemoral aortic valve replacement with the edwards sapien and edwards sapien xt prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv 5:461–467CrossRefPubMed
8.
Zurück zum Zitat Glenski JA, Friesen RH, Berglund NL, Hassanein RS, Henry DB (1988) Comparison of the hemodynamic and echocardiographic effects of sufentanil, fentanyl, isoflurane, and halothane for pediatric cardiovascular surgery. J Cardiothorac Anesth 2:147–155CrossRefPubMed Glenski JA, Friesen RH, Berglund NL, Hassanein RS, Henry DB (1988) Comparison of the hemodynamic and echocardiographic effects of sufentanil, fentanyl, isoflurane, and halothane for pediatric cardiovascular surgery. J Cardiothorac Anesth 2:147–155CrossRefPubMed
9.
Zurück zum Zitat Jobeir A, Galal MO, Bulbul ZR, Solymar L, Darwish A, Schmaltz AA (2003) Use of low-dose ketamine and/or midazolam for pediatric cardiac catheterization. Pediatr Cardiol 24:236–243CrossRefPubMed Jobeir A, Galal MO, Bulbul ZR, Solymar L, Darwish A, Schmaltz AA (2003) Use of low-dose ketamine and/or midazolam for pediatric cardiac catheterization. Pediatr Cardiol 24:236–243CrossRefPubMed
10.
Zurück zum Zitat Lewis SC, Warlow CP, Bodenham AR, Colam B, Rothwell PM, Torgerson D, Dellagrammaticas D, Horrocks M, Liapis C, Banning AP, Gough M, Gough MJ (2008) General anaesthesia versus local anaesthesia for carotid surgery (gala): a multicentre, randomised controlled trial. Lancet 372:2132–2142CrossRefPubMed Lewis SC, Warlow CP, Bodenham AR, Colam B, Rothwell PM, Torgerson D, Dellagrammaticas D, Horrocks M, Liapis C, Banning AP, Gough M, Gough MJ (2008) General anaesthesia versus local anaesthesia for carotid surgery (gala): a multicentre, randomised controlled trial. Lancet 372:2132–2142CrossRefPubMed
11.
Zurück zum Zitat Lin CH, Hegde S, Marshall AC, Porras D, Gauvreau K, Balzer DT, Beekman RH, Torres A, Vincent JA, Moore JW, Holzer R, Armsby L, Bergersen L (2013) Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease. Pediatr Cardiol 35:140–148PubMedCentralCrossRefPubMed Lin CH, Hegde S, Marshall AC, Porras D, Gauvreau K, Balzer DT, Beekman RH, Torres A, Vincent JA, Moore JW, Holzer R, Armsby L, Bergersen L (2013) Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease. Pediatr Cardiol 35:140–148PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Myles PS, Leslie K, McNeil J, Forbes A, Chan MTV (2004) Bispectral index monitoring to prevent awareness during anaesthesia: the b-aware randomised controlled trial. Lancet 363:1757–1763CrossRefPubMed Myles PS, Leslie K, McNeil J, Forbes A, Chan MTV (2004) Bispectral index monitoring to prevent awareness during anaesthesia: the b-aware randomised controlled trial. Lancet 363:1757–1763CrossRefPubMed
13.
Zurück zum Zitat Odegard KC, Bergersen L, Thiagarajan R, Clark L, Shukla A, Wypij D, Laussen PC (2014) The frequency of cardiac arrests in patients with congenital heart disease undergoing cardiac catheterization. Anesth Analg 118(175–182):1. doi:10.1213/ANE.1210b1013e3182908bcb Odegard KC, Bergersen L, Thiagarajan R, Clark L, Shukla A, Wypij D, Laussen PC (2014) The frequency of cardiac arrests in patients with congenital heart disease undergoing cardiac catheterization. Anesth Analg 118(175–182):1. doi:10.​1213/​ANE.​1210b1013e318290​8bcb
14.
Zurück zum Zitat Ramamoorthy C, Haberkern CM, Bhananker SM, Domino KB, Posner KL, Campos JS, Morray JP (2010) Anesthesia-related cardiac arrest in children with heart disease: data from the pediatric perioperative cardiac arrest (poca) registry. Anesth Analg 110(5):1376–1382CrossRefPubMed Ramamoorthy C, Haberkern CM, Bhananker SM, Domino KB, Posner KL, Campos JS, Morray JP (2010) Anesthesia-related cardiac arrest in children with heart disease: data from the pediatric perioperative cardiac arrest (poca) registry. Anesth Analg 110(5):1376–1382CrossRefPubMed
16.
Zurück zum Zitat Rivenes SM, Lewin MB, Stayer SA, Bent ST, Schoenig HM, McKenzie ED, Fraser CD, Andropoulos DB (2001) Cardiovascular effects of sevoflurane, isoflurane, halothane, and fentanyl-midazolam in children with congenital heart disease: an echocardiographic study of myocardial contractility and hemodynamics. Anesthesiology 94:223–229CrossRefPubMed Rivenes SM, Lewin MB, Stayer SA, Bent ST, Schoenig HM, McKenzie ED, Fraser CD, Andropoulos DB (2001) Cardiovascular effects of sevoflurane, isoflurane, halothane, and fentanyl-midazolam in children with congenital heart disease: an echocardiographic study of myocardial contractility and hemodynamics. Anesthesiology 94:223–229CrossRefPubMed
18.
Zurück zum Zitat Williams DB, Kiernan PD, Metke MP, Marsh HM, Danielson GK (1984) Hemodynamic response to positive end-expiratory pressure following right atrium-pulmonary artery bypass (fontan procedure). J Thorac Cardiovasc Surg 87:856–861PubMed Williams DB, Kiernan PD, Metke MP, Marsh HM, Danielson GK (1984) Hemodynamic response to positive end-expiratory pressure following right atrium-pulmonary artery bypass (fontan procedure). J Thorac Cardiovasc Surg 87:856–861PubMed
19.
Zurück zum Zitat Williams GD, Jones TK, Hanson KA, Morray JP (1999) The hemodynamic effects of propofol in children with congenital heart disease. Anesth Analg 89:1411–1416PubMed Williams GD, Jones TK, Hanson KA, Morray JP (1999) The hemodynamic effects of propofol in children with congenital heart disease. Anesth Analg 89:1411–1416PubMed
Metadaten
Titel
Sedation and Anesthesia in Pediatric and Congenital Cardiac Catheterization: A Prospective Multicenter Experience
verfasst von
C. Huie Lin
Sanyukta Desai
Ramzi Nicolas
Kimberlee Gauvreau
Susan Foerster
Anshuman Sharma
Laurie Armsby
Audrey C. Marshall
Kirsten Odegard
James DiNardo
Julie Vincent
Howaida El-Said
James Spaeth
Bryan Goldstein
Ralf Holzer
Jackie Kreutzer
David Balzer
Lisa Bergersen
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2015
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-015-1167-8

Weitere Artikel der Ausgabe 7/2015

Pediatric Cardiology 7/2015 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.